Verastem Oncology prices $90 million stock offering at $7.25 per share Nov 14, 2025 12:41AM
Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants Nov 14, 2025 12:41AM
Verastem Oncology announces public offering of common stock Nov 13, 2025 04:07PM
Verastem Oncology Announces Proposed Public Offering of Common Stock Nov 13, 2025 04:07PM
Cantor Fitzgerald Reiterates Overweight Rating on Verastem (VSTM) on Dual-Program Growth Potential Oct 20, 2025 07:40AM


Oct 16, 2025 06:24AM Cantor Fitzgerald Assumes Verastem (VSTM) at Overweight
Jun 3, 2025 07:08AM Cantor Fitzgerald Reiterates Overweight Rating on Verastem (VSTM)
Jul 23, 2024 11:20PM Verastem Oncology Announces Pricing of $55.0 Million Public Offering of Common Stock, Warrants and Pre-Funded Warrants
Jul 23, 2024 04:07PM Verastem Oncology (VSTM) Announces Proposed Share Offering
Jul 23, 2024 04:05PM Verastem Oncology Announces Proposed Public Offering of Common Stock, Warrants and Pre-Funded Warrants
Jun 16, 2023 05:54AM Verastem Oncology (VSTM) Prices 7.18M Share and Warrant Offering at $9.75/sh
Jun 16, 2023 05:00AM Verastem Oncology Announces Pricing of $85.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Jun 15, 2023 04:00PM Verastem Oncology (VSTM) Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jun 15, 2023 04:00PM Verastem Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Apr 3, 2019 06:42AM UPDATE: Cantor Fitzgerald Starts Verastem (VSTM) at Overweight
Sep 27, 2018 04:05PM Verastem Oncology to Present at Upcoming Investor Conferences
Jun 15, 2018 09:08AM Verastem (VSTM) Capital Raise Removes Overhang - Cantor Fitzgerald
May 23, 2018 04:05PM Verastem Oncology Announces Closing of Underwriter’s Option to Purchase Additional Shares
May 16, 2018 09:30AM Verastem Inc. (VSTM) Prices 7.78M Share Common Offerings at $4.50/Sh
May 16, 2018 09:29AM Verastem Oncology Announces Pricing of Public Offering of Common Stock
May 15, 2018 04:03PM Verastem (VSTM) Commences $35M Common Stock Offering
May 15, 2018 04:01PM Verastem Oncology Announces Public Offering of Common Stock
Dec 15, 2017 09:28AM Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)
Dec 14, 2017 06:22PM After-Hours Stock Movers 12/14: (DDR) (HES) (DISCA) Higher; (VSTM) (APHB) (ORCL) Lower (more...)
Sep 22, 2017 07:15AM Verastem to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 6, 2017 09:04AM Cantor Fitzgerald Upgrades Verastem (VSTM) to Overweight
Jun 8, 2017 09:30AM Pre-Open Movers 06/08: (JWN) (BABA) (VSTM) Higher; (NLNK) (GEF) (MZOR) Lower (more...)
Jun 7, 2017 05:34PM After-Hours Stock Movers 06/07: (VSTM) (OKTA) (MESO) Higher; (GEF) (MSL) Lower (more...)
Jul 6, 2016 07:00AM Verastem to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Jan 13, 2016 07:52AM Cantor Fitzgerald Upgrades Verastem (VSTM) to Spec. Buy
Sep 28, 2015 05:10PM Cantor Fitzgerald Downgrades Verastem (VSTM) to Hold
Jul 2, 2015 07:00AM Verastem to Present at Cantor Fitzgerald’s Inaugural Health Care Conference
Jul 17, 2013 09:25AM Verastem (VSTM) Prices $51.9M Common Stock Offering
Jul 9, 2013 10:42AM Notable Analyst Rating Changes 07/09: (S) (HPQ) (YY) Upgraded; (NEM) (ISRG) (IBM) Downgraded
Jul 9, 2013 08:32AM Verastem (VSTM) on 'Cutting Edge of Cancer'; Cantor Fitzgerald Starts at Buy